These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 4575429

  • 1. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
    Megna GF, Puca FM, Leggiadro N, Micalizzi V, Pigneri MT.
    Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K, Mutsuga N, Takaoka Y, Takeda A.
    No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract] [Full Text] [Related]

  • 3. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA, Schneider E, Jacobi P, Maxion H.
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T.
    No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative evaluation of the results obtained with surgical treatment and L-dopa in parkinsonism].
    D'Andrea F, DeDivitiis E, Signorelli CD.
    Sist Nerv; 1970 Dec; 22(2):206-11. PubMed ID: 4928972
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
    Kaufmann W, Butz P, Wiesendanger M.
    Dtsch Z Nervenheilkd; 1969 Dec 29; 197(1):85-100. PubMed ID: 5364658
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov 29; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 17. [Comparative analysis of the effects of Levodopa on sleep in patients with athetosis and parkinsonism treated and not treated with thalamolysis].
    Puca FM, Di Perri R.
    Riv Neurol; 1970 Nov 29; 40(5):365-73. PubMed ID: 5503726
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Evolution of intellectual potential and memory in Parkinsonism patients treated with L-dopa].
    Vernet JP, Novi M, Sevilla M, Becle J, Lavagna J, Darcourt G.
    Ann Med Psychol (Paris); 1973 Mar 29; 1(3):413-27. PubMed ID: 4722004
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.